No Data
No Data
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $9
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7
HC Wainwright & Co. Reiterates Buy on Absci, Maintains $7 Price Target
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating
Absci Shares Are Trading Higher After the Company Highlighted Progress and Updates Across Its Proprietary Pipeline and Leading AI Platform on 2024 R&D Day. Its Drug Candidate Was Selected for ABS-201, an Anti-PRLR Antibody in Development for...
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day
No Data